Novo Nordisk, the Danish drugmaker behind the global weight-loss sensations Ozempic and Wegovy, has launched an unsolicited 9 ...
Plus, how a little-known Utah lender became First Brands’ biggest creditor and Novo Nordisk gatecrashes Pfizer’s latest deal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback